Moleculin Biotech
MBRX
MBRX
20 hedge funds and large institutions have $1.85M invested in Moleculin Biotech in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$175K | |
| 2 | +$156K | |
| 3 | +$117K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$23K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$19K |
Top Sellers
| 1 | -$21K | |
| 2 | -$4K | |
| 3 | -$1.28K | |
| 4 |
Morgan Stanley
New York
|
-$821 |